Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: Results from the cervical, endometrial, and ovarian cancer cohorts of the destiny-PanTumor02 study Meeting Abstract
| Authors: | Lee, J. Y.; Makker, V.; Manso, L.; González-Martín, A.; Lugowska, I.; Lorusso, D.; Banerjee, S.; Liao, J.; Lu, C. H.; Prasongsook, N.; Melichar, B.; Chen, K.; McEwen, R.; Michelini, F.; Puvvada, S.; Meric-Bernstam, F.; Oaknin, A. |
| Abstract Title: | Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: Results from the cervical, endometrial, and ovarian cancer cohorts of the destiny-PanTumor02 study |
| Meeting Title: | IGCS 2023 Annual Meeting |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 33 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2023 Nov 5-7 |
| Meeting Location: | Seoul, South Korea |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2023-11-01 |
| Start Page: | A6 |
| End Page: | A7 |
| Language: | English |
| ACCESSION: | WOS:001262421600037 |
| DOI: | 10.1136/ijgc-2023-IGCS.7 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: PO007LBA/#1550 -- Source: Wos |
